应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NRIX Nurix Therapeutics
盘后交易 07-15 16:50:06 EDT
12.15
-0.54
-4.26%
盘后
12.15
+0.00
0.00%
16:24 EDT
最高
12.68
最低
12.11
成交量
105.28万
今开
12.68
昨收
12.69
日振幅
4.49%
总市值
9.29亿
流通市值
7.04亿
总股本
7,645万
成交额
1,293万
换手率
1.82%
流通股本
5,796万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Nurix Therapeutics Q2销售额同比大增264.34%,远超市场预期
老虎资讯综合 · 07-10
Nurix Therapeutics Q2销售额同比大增264.34%,远超市场预期
异动解读 | 业绩超预期,Nurix Therapeutics盘前大涨28.60%
异动解读 · 07-10
异动解读 | 业绩超预期,Nurix Therapeutics盘前大涨28.60%
异动解读 | 业绩超预期,Nurix Therapeutics夜盘大涨16.31%
异动解读 · 07-10
异动解读 | 业绩超预期,Nurix Therapeutics夜盘大涨16.31%
Nurix Therapeutics, Inc.盘中异动 下午盘股价大涨5.05%
市场透视 · 05-20
Nurix Therapeutics, Inc.盘中异动 下午盘股价大涨5.05%
Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.16%
市场透视 · 05-12
Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.16%
Nurix Therapeutics, Inc.盘中异动 股价大涨5.05%报9.77美元
市场透视 · 05-08
Nurix Therapeutics, Inc.盘中异动 股价大涨5.05%报9.77美元
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%
市场透视 · 04-22
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%
Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元
市场透视 · 04-21
Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元
Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元
市场透视 · 04-16
Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元
Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%
市场透视 · 03-03
Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%
Nurix Therapeutics, Inc.盘中异动 股价大跌5.10%
市场透视 · 02-27
Nurix Therapeutics, Inc.盘中异动 股价大跌5.10%
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%报16.01美元
市场透视 · 02-25
Nurix Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%报16.01美元
Nurix Therapeutics, Inc.盘中异动 股价大跌5.00%报17.11美元
市场透视 · 02-11
Nurix Therapeutics, Inc.盘中异动 股价大跌5.00%报17.11美元
Nurix Therapeutics, Inc.盘中异动 大幅上涨5.00%报19.52美元
市场透视 · 02-05
Nurix Therapeutics, Inc.盘中异动 大幅上涨5.00%报19.52美元
Nurix Therapeutics, Inc.盘中异动 临近收盘急速跳水5.07%报18.71美元
市场透视 · 02-03
Nurix Therapeutics, Inc.盘中异动 临近收盘急速跳水5.07%报18.71美元
Nurix Therapeutics, Inc.2024财年实现净利润-1.94亿美元,同比减少34.72%
市场透视 · 01-30
Nurix Therapeutics, Inc.2024财年实现净利润-1.94亿美元,同比减少34.72%
加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。
金融界 · 01-29
加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。
小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。
金融界 · 01-29
小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。
Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。
金融界 · 01-29
Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。
HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。
金融界 · 01-29
HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。
加载更多
公司概况
公司名称:
Nurix Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nurix Therapeutics, Inc.于2009年8月27日在特拉华州成立。该公司是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为癌症和免疫紊乱的新治疗方法。利用他们在E3连接酶方面的广泛专业知识以及他们的专有DNA编码库,该公司已经建立了一个集成的发现平台DELigase,以识别和开发针对E3连接酶的新药物候选。
发行价格:
--
{"stockData":{"symbol":"NRIX","market":"US","secType":"STK","nameCN":"Nurix Therapeutics","latestPrice":12.15,"timestamp":1752609600000,"preClose":12.69,"halted":0,"volume":1052790,"hourTrading":{"tag":"盘后","latestPrice":12.15,"preClose":12.15,"latestTime":"16:24 EDT","volume":53483,"amount":649817.754721,"timestamp":1752611067400},"delay":0,"floatShares":57962173,"shares":76449355,"eps":-2.602838,"marketStatus":"盘后交易","change":-0.54,"latestTime":"07-15 16:50:06 EDT","open":12.68,"high":12.68,"low":12.11,"amount":12927473.71308,"amplitude":0.044917,"askPrice":12.59,"askSize":600,"bidPrice":12.08,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.602838,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752624000000},"marketStatusCode":4,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":12.69,"preHourTrading":{"tag":"盘前","latestPrice":12.63,"preClose":12.69,"latestTime":"09:25 EDT","volume":171,"amount":2144.6795205,"timestamp":1752585910001},"postHourTrading":{"tag":"盘后","latestPrice":12.15,"preClose":12.15,"latestTime":"16:24 EDT","volume":53483,"amount":649817.754721,"timestamp":1752611067400},"volumeRatio":0.629462,"impliedVol":0.9049,"impliedVolPercentile":0.64},"requestUrl":"/m/hq/s/NRIX","defaultTab":"news","newsList":[{"id":"1198497678","title":"Nurix Therapeutics Q2销售额同比大增264.34%,远超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1198497678","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198497678?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:30","pubTimestamp":1752136248,"startTime":"0","endTime":"0","summary":"7月10日,生物医药股$Nurix Therapeutics(NRIX)$盘前暴涨逾30%!该公司第二季度销售额同比大增264.34%,远超市场预期>>","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nurix Therapeutics Q2销售额同比大增264.34%,远超市场预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4007","NRIX"],"gpt_icon":0},{"id":"1161625950","title":"异动解读 | 业绩超预期,Nurix Therapeutics盘前大涨28.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161625950","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161625950?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:21","pubTimestamp":1752135660,"startTime":"0","endTime":"0","summary":"周四盘前,生物技术公司Nurix Therapeutics股价大幅飙升28.60%,引发市场广泛关注。这一显著涨幅主要源于公司最新发布的季度财报远超市场预期。根据公司公告,截至5月31日的季度财报显示,Nurix Therapeutics调整后每股亏损为0.52美元,明显优于分析师平均预期的0.73美元亏损。值得注意的是,分析师对Nurix Therapeutics的评级普遍较为积极。这种积极的市场情绪,加上超预期的财报表现,共同推动了公司股价的大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NRIX"],"gpt_icon":0},{"id":"1152122372","title":"异动解读 | 业绩超预期,Nurix Therapeutics夜盘大涨16.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152122372","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152122372?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:37","pubTimestamp":1752133061,"startTime":"0","endTime":"0","summary":"生物技术公司Nurix Therapeutics在夜盘交易中股价大涨16.31%,引起投资者广泛关注。这一显著涨幅主要源于公司最新发布的季度财报超出市场预期。根据公司公告,截至5月31日的季度财报显示,Nurix Therapeutics调整后每股亏损为0.52美元,明显优于分析师平均预期的0.73美元亏损。值得注意的是,目前分析师对Nurix Therapeutics的评级普遍较为积极。这种积极的市场情绪可能进一步推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NRIX"],"gpt_icon":0},{"id":"2537664748","title":"Nurix Therapeutics, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537664748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537664748?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:06","pubTimestamp":1747764362,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时06分,Nurix Therapeutics, Inc.股票出现异动,股价急速拉升5.05%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020602aa2c946c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020602aa2c946c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","NRIX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2534276316","title":"Nurix Therapeutics, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534276316?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056725,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分,Nurix Therapeutics, Inc.股票出现波动,股价急速上涨5.16%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221320594f481a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221320594f481a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","NRIX"],"gpt_icon":0},{"id":"2534151819","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.05%报9.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534151819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534151819?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:19","pubTimestamp":1746721174,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时19分,Nurix Therapeutics, Inc.股票出现异动,股价快速上涨5.05%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.18%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509001934aa2c87f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509001934aa2c87f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRIX","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2529352935","title":"Nurix Therapeutics, Inc.盘中异动 临近午盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529352935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529352935?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:43","pubTimestamp":1745336605,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时43分,Nurix Therapeutics, Inc.股票出现异动,股价急速上涨5.31%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.83%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422234325aa2c7683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422234325aa2c7683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2529338536","title":"Nurix Therapeutics, Inc.盘中异动 股价大涨5.47%报10.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529338536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529338536?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:39","pubTimestamp":1745246371,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时39分,Nurix Therapeutics, Inc.股票出现波动,股价急速上涨5.47%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223932a4613096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223932a4613096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139","BK4007"],"gpt_icon":0},{"id":"2527724493","title":"Nurix Therapeutics, Inc.盘中异动 大幅跳水5.19%报9.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527724493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527724493?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:08","pubTimestamp":1744812494,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时08分,Nurix Therapeutics, Inc.股票出现波动,股价急速跳水5.19%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.41%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220814a6bcabc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220814a6bcabc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2516658359","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516658359?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:35","pubTimestamp":1741016156,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时35分,Nurix Therapeutics, Inc.股票出现异动,股价急速跳水5.18%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.36%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032335579637bcd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032335579637bcd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRIX"],"gpt_icon":0},{"id":"2514331683","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514331683?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:39","pubTimestamp":1740677995,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时39分,Nurix Therapeutics, Inc.股票出现异动,股价大幅下跌5.10%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801395598953419&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801395598953419&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2514726011","title":"Nurix Therapeutics, Inc.盘中异动 临近午盘股价大跌5.04%报16.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514726011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514726011?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:38","pubTimestamp":1740501495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时38分,Nurix Therapeutics, Inc.股票出现异动,股价大幅跳水5.04%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为一种新型治疗癌症和免疫紊乱的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600381696300d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600381696300d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRIX"],"gpt_icon":0},{"id":"2510353845","title":"Nurix Therapeutics, Inc.盘中异动 股价大跌5.00%报17.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510353845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510353845?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:07","pubTimestamp":1739297270,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时07分,Nurix Therapeutics, Inc.股票出现波动,股价大幅下挫5.00%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.46%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212020751961f6c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212020751961f6c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ","BK4139"],"gpt_icon":0},{"id":"2509231285","title":"Nurix Therapeutics, Inc.盘中异动 大幅上涨5.00%报19.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509231285?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:24","pubTimestamp":1738776295,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时24分,Nurix Therapeutics, Inc.股票出现异动,股价急速拉升5.00%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.06%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206012455a23aa149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206012455a23aa149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRIX"],"gpt_icon":0},{"id":"2508178878","title":"Nurix Therapeutics, Inc.盘中异动 临近收盘急速跳水5.07%报18.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508178878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508178878?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:44","pubTimestamp":1738615480,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时44分,Nurix Therapeutics, Inc.股票出现波动,股价大幅跳水5.07%。Nurix Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Nurix Therapeutics, Inc.公司简介:Nurix Therapeutics Inc是一家生物制药公司,专注于口服,小分子疗法的发现,开发和商业化,这些疗法旨在调节细胞蛋白水平,作为癌症和免疫疾病的新型治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204044440abc15275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204044440abc15275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRIX","BK4139"],"gpt_icon":0},{"id":"2507692295","title":"Nurix Therapeutics, Inc.2024财年实现净利润-1.94亿美元,同比减少34.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507692295","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507692295?lang=zh_cn&edition=full","pubTime":"2025-01-30 12:01","pubTimestamp":1738209666,"startTime":"0","endTime":"0","summary":"1月30日,Nurix Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-1.94亿美元,同比减少34.72%;其中营业收入为54.55百万美元,同比减少29.15%,每股基本收益为-2.88美元。机构评级:截至2025年1月30日,当前有17家机构对Nurix Therapeutics, Inc.目标价做出预测,其中目标均价为33.18美元,其中最低目标价为26.00美元,最高目标价为41.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130120118a233ed05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130120118a233ed05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"2507659941","title":"加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507659941","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507659941?lang=zh_cn&edition=full","pubTime":"2025-01-30 01:36","pubTimestamp":1738172215,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Nurix Therapeutics(NRIX.US)评级,由优于大市调整至优于大市评级, 目标价由26.00美元调整至27.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30013647899048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NRIX","LENZ"],"gpt_icon":0},{"id":"2507398356","title":"小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507398356","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507398356?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:04","pubTimestamp":1738159446,"startTime":"0","endTime":"0","summary":"小摩:维持Nurix Therapeutics(NRIX.US)评级,由增持调整至增持评级, 目标价由31.00美元调整至30.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29220447898251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NRIX"],"gpt_icon":0},{"id":"2507633778","title":"Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507633778","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507633778?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:22","pubTimestamp":1738156968,"startTime":"0","endTime":"0","summary":"Stifel:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由34.00美元调整至36.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29212247898164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","NRIX"],"gpt_icon":0},{"id":"2507843680","title":"HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507843680","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507843680?lang=zh_cn&edition=full","pubTime":"2025-01-29 20:20","pubTimestamp":1738153253,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Nurix Therapeutics(NRIX.US)评级,由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29202047897457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NRIX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nurixtx.com","stockEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0637},{"period":"3month","weight":0.2923},{"period":"6month","weight":-0.3702},{"period":"1year","weight":-0.4673},{"period":"ytd","weight":-0.3264}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nurix Therapeutics, Inc.于2009年8月27日在特拉华州成立。该公司是一家生物制药公司,专注于发现、开发和商业化口服小分子疗法,旨在调节细胞蛋白水平,作为癌症和免疫紊乱的新治疗方法。利用他们在E3连接酶方面的广泛专业知识以及他们的专有DNA编码库,该公司已经建立了一个集成的发现平台DELigase,以识别和开发针对E3连接酶的新药物候选。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.063877},{"month":2,"riseRate":0.2,"avgChangeRate":-0.007659},{"month":3,"riseRate":0.2,"avgChangeRate":-0.071924},{"month":4,"riseRate":0.4,"avgChangeRate":-0.043438},{"month":5,"riseRate":0.4,"avgChangeRate":-0.000824},{"month":6,"riseRate":0.6,"avgChangeRate":0.118065},{"month":7,"riseRate":0.8,"avgChangeRate":0.110572},{"month":8,"riseRate":0.6,"avgChangeRate":0.053338},{"month":9,"riseRate":0.2,"avgChangeRate":0.013466},{"month":10,"riseRate":0.4,"avgChangeRate":-0.0754},{"month":11,"riseRate":0.4,"avgChangeRate":0.106468},{"month":12,"riseRate":0.4,"avgChangeRate":0.034689}],"exchange":"NASDAQ","name":"Nurix Therapeutics","nameEN":"Nurix Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nurix Therapeutics,NRIX,Nurix Therapeutics股票,Nurix Therapeutics股票老虎,Nurix Therapeutics股票老虎国际,Nurix Therapeutics行情,Nurix Therapeutics股票行情,Nurix Therapeutics股价,Nurix Therapeutics股市,Nurix Therapeutics股票价格,Nurix Therapeutics股票交易,Nurix Therapeutics股票购买,Nurix Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nurix Therapeutics(NRIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nurix Therapeutics(NRIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}